Robatumumab - AbsoluteAstronomy.com

Robatumumab is a monoclonal antibody and an antineoplastic by Schering-Plough

Schering-Plough

Schering-Plough Corporation was a United States-based pharmaceutical company. It was founded in 1851 by Ernst Christian Friedrich Schering as Schering AG in Germany. In 1971, the Schering Corporation merged with Plough to form Schering-Plough. On November 4, 2009 Merck & Co...

. It binds to CD221, the insulin-like growth factor 1 receptor.

The source of this article is wikipedia, the free encyclopedia. The text of this article is licensed under the GFDL.